2000 Collective Safety Treatment 
Cannabis Law Report
DECEMBER 1, 2021
Ethics, Safety, and Abuse in Psychedelic Medicine. Vilmarie Fraguada Narloch, PsyD, is a licensed clinical psychologist in Chicago, Illinois, focusing on integrated treatment of co-occurring mental health and substance use disorders and psychedelic-assisted therapy. Wednesday, December 8th from 12:00-2:00pm PST. Kylea Taylor, M.S.,
Cannabis Law Report
JULY 19, 2021
We are in a mental health crisis and its critical to ensure that we conduct clinical trials to demonstrate safety, and efficacy up to and including phase 3 large scale clinical trials. Extensive early phase experience with appropriate safety oversight and early phase clinic.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Blunt Truth
AUGUST 13, 2019
On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety. The public hearing attracted over 100 speakers and 2000 participants. The FDA is collecting data to fill these gaps.
Veriheal
OCTOBER 29, 2020
billion was funded into cannabis research between 2000 and 2018. On the brighter side, Science Magazine has indicated that the funding for cannabis as an effective form of treatment and therapy is rising, however not as much as the funding for its adverse impacts are. How could we move the focus towards understanding the benefits?
The Joint Blog
APRIL 21, 2020
For the study researchers with the Nordic Cannabis Research Institute in Denmark reviewed 25 clinical trials assessing the safety and efficacy of CBD in various populations. ” The study is titled Dosage, efficacy, and safety of cannabidiol administration in adults: A systematic review of human trials.
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).
Cannabis Law Report
OCTOBER 29, 2019
ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., Dr. Wakshlag is currently available for interviews to discuss the results of the safety study as well as his clinical trials.
Expert insights. Personalized for you.
52 
Let's personalize your content